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ing from mutations in  LMNA and  ZMPSTE24 , respectively. 
 ZMPSTE24 in addition to  ICMT  encode proteins involved in 
posttranslational processing of lamin A. We hypothesized 
that HSS is an allelic disorder to HGPS and MAD. As the nu-
clear shape is often irregular in patients with  LMNA muta-
tions, we first analyzed the nuclear morphology in skin fibro-
blasts of patients with HSS, but could not identify any abnor-
mality. Sequencing of the genes  LMNA, ZMPSTE24 and ICMT 
in the 8 patients with HSS revealed the heterozygous mis-
sense mutation c.1930C 1 T (p.R644C) in  LMNA in 1 female. 
Extreme phenotypic diversity and low penetrance have 
been associated with the p.R644C mutation. In  ZMPSTE24 
and  ICMT , no pathogenic sequence change was detected in 
patients with HSS. Together, we found no evidence that HSS 
is another laminopathy.  
 
Copyright © 2011 S. Karger AG, Basel 
 Hallermann-Streiff syndrome (HSS, MIM 234100) is 
a rare congenital disorder characterized by cranial and 
facial bone malformation, hypotrichosis, microphthal-
mia, cataracts, skin atrophy, dental anomalies, and pro-
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 Abstract 
 Hallermann-Streiff syndrome (HSS) is a rare inherited disor-
der characterized by malformations of the cranium and facial 
bones, congenital cataracts, microphthalmia, skin atrophy, 
hypotrichosis, proportionate short stature, teeth abnormali-
ties, and a typical facial appearance with prominent fore-
head, small pointed nose, and micrognathia. The genetic 
cause of this developmental disorder is presently unknown. 
Here we describe 8 new patients with a phenotype of HSS. 
Individuals with HSS present with clinical features overlap-
ping with some progeroid syndromes that belong to the 
laminopathies, such as Hutchinson-Gilford progeria syn-
drome (HGPS) and mandibuloacral dysplasia (MAD). HGPS is 
caused by de novo point mutations in the  LMNA gene, cod-
ing for the nuclear lamina proteins lamin A and C. MAD with 
type A and B lipodystrophy are recessive disorders result-
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portionate short stature. The condition can be immedi-
ately recognized by a characteristic facial gestalt with 
small face, prominent forehead, thin narrow nose, and 
micrognathia. Although a few familial cases have been 
reported [Guyard et al., 1962; Koliopoulos and Palimeris, 
1975; Gerinec et al., 1989], all classical cases are sporadic 
[Cohen, 1991]. Inheritance of this developmental disor-
der is still unknown, and autosomal recessive as well as 
autosomal dominant inheritance with de novo mutations 
have been discussed. 
 Conventional cytogenetic studies revealed normal 
chromosomes in the majority of cases. However, Carones 
[1961] reported some discrepancy in the size of 2 D-group 
chromosomes in an individual with HSS, Jalbert et al. 
[1968] noted a 4p anomaly in 1 patient with HSS, and 
Fryns et al. [1993] described a girl with clinical features 
compatible with HSS and a partial 4q monosomy and a 
partial 14q trisomy. However, no clue to the localization 
of the causative gene for HSS in the genome exists so far. 
Thus, by screening candidate genes implicated in con-
genital disorders with clinical manifestations overlap-
ping HSS, the underlying genetic defect in HSS-affected 
patients could be identified. For example, dominantly 
inherited oculodentodigital dysplasia (ODDD, MIM 
164200) that shares several clinical characteristics with 
HSS, such as microphthalmia, small nose, hypotrichosis, 
and dental anomalies, is caused by mutations in  GJA1 
 [Paznekas et al., 2003]. In a patient with phenotypic over-
lap with HSS [Damiano Salpietro et al., 2004], the homo-
zygous missense mutation c.227G 1 A (p.R76H) in  GJA1 
was found, while no sequence alteration in this gene was 
detected in another patient with full-blown HSS [Pizzuti 
et al., 2004]. 
 Patients with HSS have a progeroid appearance with 
small face, pointed nose, micrognathia, and hypotricho-
sis, all features that are also present in individuals with 
Hutchinson-Gilford progeria syndrome (HGPS, MIM 
176670) and mandibuloacral dysplasia with type A or B 
lipodystrophy (MADA, MIM 248370; MADB, MIM 
608612). Indeed, in a female patient with MAD, the clin-
ical diagnosis of HSS has been suggested at the age of 2 
years because of her characteristic facial appearance 
[Schrander-Stumpel et al., 1992]. HGPS is a rare progres-
sive disorder characterized by extreme premature ageing. 
Patients with MAD, a progeria-like syndrome with auto-
somal recessive inheritance, have growth retardation, 
craniofacial anomalies, skeletal abnormalities with pro-
gressive acro-osteolysis, pigmentary skin changes, and 
lipodystrophy type A or B. HGPS and MADA are both 
caused by mutations in the  LMNA gene encoding lamins 
A and C [Novelli et al., 2002; De Sandre-Giovannoli et al., 
2003; Eriksson et al., 2003]. Lamins are part of the nucle-
ar envelope of all somatic cells.  LMNA mutations have 
been implicated in a wide spectrum of diseases that in-
clude disorders of the striated muscle, peripheral neurop-
athy, syndromes affecting adipose tissue and accelerated 
ageing disorders [Novelli and D’Apice, 2003; Worman et 
al., 2009]. In individuals affected by MADB, no sequence 
alteration in  LMNA has been detected, suggesting a dif-
ferent genetic cause than in MADA [Simha et al., 2003]. 
Indeed, biallelic mutations in the  ZMPSTE24 gene have 
been identified in patients with MADB [Agarwal et al., 
2003; Miyoshi et al., 2008; Cunningham et al., 2010; Ah-
mad et al., 2011; Yaou et al., 2011].  ZMPSTE24 encodes a 
zinc metalloproteinase which is required for posttransla-
tional processing of the precursor molecule of lamin A, 
called prelamin A [Barrowman and Michaelis, 2009]: 
first, ZMPSTE24 cleaves off the last 3 amino acids of the 
farnesylated prelamin A. Second, following methylation 
of the farnesylated cysteine residue at the C-terminus by 
the isoprenylcysteine carboxyl methyltransferase (ICMT) 
[Sinensky et al., 1994], ZMPSTE24 cleaves the last 15 
amino acids to generate mature lamin A. Involvement of 
ICMT in prelamin A processing suggests that  ICMT is a 
candidate gene for MAD-related disorders. However, no 
mutation in the  ICMT gene has yet been linked to human 
diseases. 
 Due to the clinical overlap between progeria, MAD, 
and HSS, we hypothesized that the 3 conditions are al-
lelic. Here we summarize clinical data of 8 patients with 
HSS and describe our results on chromosome breakage, 
nuclear morphology, and sequence analysis of the genes 
 LMNA ,  ZMPSTE24 , and  ICMT in our cohort of HSS-af-
fected individuals.
 Material and Methods 
 Patients 
 We obtained clinical data and blood or DNA samples from 8 
patients with a phenotype compatible with the clinical diagnosis 
of HSS who were assessed by experienced clinical geneticists and/
or pediatricians. Routine chromosome analysis was performed on 
a clinical basis for all patients. The clinical data and samples were 
obtained with informed consent, including consent to use the 
photographs in this report, under protocols approved by Institu-
tional Review Boards at all participating institutions. 
 Chromosome Breakage Studies 
 Blood samples were obtained from patients 2 and 3 as well as 
a healthy individual for chromosomal instability studies, i.e. test-
ing for hypersensitivity to the clastogenic effect of the DNA cross-
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linking agent diepoxybutane (DEB; Sigma-Aldrich, Taufkirchen, 
Germany). For these studies, cultures of stimulated peripheral 
blood lymphocytes were paired with a replicate set of untreated 
controls used to measure spontaneous breakage. After initial in-
cubation for 24 h at 37   °   C, DEB (final concentration 0.1   g/ml) 
was added to the treated cultures for further 48 h. Cultures were 
harvested and chromosomes were prepared according to stan-
dard protocols. Breakage analysis was performed on 100 Giemsa-
stained metaphase spreads from both the untreated and the clas-
togen-treated cultures of the patients and the control individual. 
Each cell was assayed for the number of chromosomes and the 
number and type of structural abnormalities. Chromosome dam-
age was reported as breaks per cell. To study chromosomal insta-
bility in patients 1 and 5, fibroblast cells derived from skin biop-
sies of these patients and a healthy individual were cultured under 
standard conditions. Confluent cultures were split, and 24 h later 
1 subculture from each individual was exposed to 0.01   g/ml DEB 
for 48 h, while a second one served as untreated control. After 
harvesting the cells, 50 Giemsa-stained metaphase spreads each 
were examined as described above. Testing for hyper-radiosensi-
tivity was not performed.
 Immunocytochemistry 
 Fibroblast cells (passage 9–11) derived from patients 1 and 5 
and 1 healthy individual were grown at low density on sterile cov-
erslips in DMEM (Invitrogen, Karlsruhe, Germany) supplement-
ed with 10% fetal calf serum (Invitrogen) and penicillin-strepto-
mycin (100 U/ml and 100 mg/ml) (Invitrogen) at 37  °  C in 5% CO 2 
for 20 h. Following rinsing with PBS, cells were fixed with 4% 
paraformaldehyde (Sigma-Aldrich) in PBS. After washing 3 times 
with PBS, cells were incubated in permeabilization/blocking solu-
tion (2% BSA (Sigma-Aldrich), 3% goat serum (Sigma-Aldrich), 
and 0.5% Nonidet P40 (ICN, Eschwege, Germany) in PBS). Sub-
sequently, cells were overlaid with antibody solution (3% goat se-
rum and 0.1% Nonidet P40 in PBS) containing monoclonal mouse 
anti-human lamin A/C antibody (1: 10 dilution; clone JOL2, 
Chemicon, Hofheim, Germany). After extensive washing, cells 
were incubated with 4   g/ml Alexa Fluor 546 goat anti-mouse 
IgG (Invitrogen) in antibody solution. Finally, cells were washed 
with PBS and embedded in glycerol gelatine containing 1% phenol 
(Sigma-Aldrich) on microscopic slides. Images were acquired and 
processed with a Leica TCS-NT confocal microscope system (Lei-
ca Microsystems, Wetzlar, Germany) using an APO 40-by-1.25 oil 
immersion objective lens (Leica Microsystems). 
 Sequencing of the Genes LMNA, ZMPSTE24, and ICMT 
 Genomic DNA was isolated from blood lymphocytes or fibro-
blasts according to standard procedures. The coding region, 
including flanking intronic sequences of the genes  LMNA  (12 
exons; GenBank accession nos. NM_170707 and NM_005572), 
ZMPSTE24  (10 exons; GenBank accession no. NM_005857)  and 
 ICMT  (6 exons; GenBank accession no. NM_012405),  was ampli-
fied from genomic DNA. Primer sequences and PCR conditions 
are available on request. Amplicons were directly sequenced us-
ing the ABI BigDye Terminator Sequencing Kit (Applied Biosys-
tems, Darmstadt, Germany) and an automated capillary sequenc-
er (ABI 3130 or ABI 3500; Applied Biosystems). Sequence electro-
pherograms were analyzed using Sequence Pilot software (JSI 
medical systems, Kippenheim, Germany). 
 Computational Analysis 
 Splice site prediction of 1 intronic variant identified in  LMNA 
was calculated by using the online tools SpliceView (http://bio-
info.itb.cnr.it/oriel/splice-view.html), the Berkeley Drosophila 
Genome Project (BDGP) (http://www.fruitfly.org/) [Reese et al., 
1997], and the NetGene2 server (http://www.cbs.dtu.dk/services/
NetGene2/) [Hebsgaard et al., 1996]. 
 LMNA Transcript Analysis  
 Total RNA was isolated from fibroblast cells of patient 1 and 
of 2 controls using the RNeasy Mini Kit (Qiagen, Hilden, Ger-
many) according to the manufacturer’s protocol. One micro-
gram of RNA was reverse transcribed into cDNA using the Om-
niscript Reverse Transcriptase Kit (Qiagen) and random hexa-
nucleotides (Invitrogen) according to the manufacturer’s 
recommendations. Of a total of 20   l reaction, 1   l was used as 
template to amplify transcripts by using primer pairs spanning 
all  LMNA exon-exon junctions, thereby covering the complete 
cDNA. Amplicons were visualized on an agarose gel. The ampli-
con band pattern from patient 1 was compared with that of the 
2 controls. Subsequently, amplicons of the 2 controls and patient 
1 were directly sequenced. Primer sequences and PCR condi-
tions are available on request.
 Results 
 Clinical data of the 8 individuals with HSS are sum-
marized in  table 1 , and selected photographs are shown 
in  figure 1 . 
 Conventional cytogenetic analysis revealed a normal 
karyotype in the 8 patients with HSS (data not shown). In 
2003, a patient with HSS showing a markedly increased 
chromosome breakage rate has been described, suggest-
ing that defective DNA repair may underlie HSS [Hou, 
2003]. Chromosome breakage studies using fibroblast 
cells from patients 1 and 5 and lymphocytes from indi-
viduals 2 and 3 did not reveal an increased breakage rate 
compared with cells (fibroblasts and lymphocytes) from 
healthy individuals (online suppl. table 1; for all online 
material, see www.karger.com/doi/10.1159/000334317).
 Nuclear abnormalities, including irregular shape and 
lobulation of the nuclear envelope, have been reported in 
fibroblasts of patients with different types of laminopa-
thies and  LMNA mutations [Ostlund et al., 2001; Muchir 
et al., 2004]. To study, if the lamin A/C pathway is affect-
ed in HSS, we first analyzed the nuclear shape in fibro-
blast cells of HSS-affected individuals 1 and 5 by immu-
nofluorescence analysis with an anti-lamin A/C anti-
body. We did not detect any abnormality in nuclear 
morphology of the patients’ fibroblast cells compared 
with normal cells. Nuclei showed a normal ovoid mor-
phology ( fig. 2 ). 
 Kortüm et al. Mol Syndromol 2011;2:27–3430
Ta
bl
e 
1.
  C
lin
ic
al
 d
at
a f
ro
m
 in
di
vi
du
al
s w
ith
 H
SS
Pa
tie
nt
 N
o.
1
2
3
4
5a
6
7
8b
Et
hn
ic 
or
ig
in
Ar
ab
ia
n
G
er
m
an
 (C
)
Ko
so
va
n 
(C
)
Cz
ec
h 
(C
)
Tu
rk
ish
Cz
ec
h 
(C
)
G
er
m
an
 (C
)
G
er
m
an
 (C
)
Se
x
F
F
F
M
M
M
F
M
Bi
rth
 w
eig
ht
 (S
D
)
–1
.5
–0
.5
–0
.6
–1
–1
.9
+1
.7
–0
.6
–2
.3
Bi
rth
 le
ng
th
 (S
D
)
–2
.6
+0
.1
–0
.6
0
–1
0
+0
.8
–3
.8
O
FC
 b
irt
h 
(S
D
)
–0
.9
+0
.9
m
icr
oc
ep
ha
ly
nd
–2
0
–0
.9
–2
.8
O
FC
* (
SD
) 
–2
.6
+0
.9
–2
.9
–1
nd
–0
.2
–2
.0
–1
0
H
eig
ht
* (
SD
)
–4
.2
–1
–4
.4
+0
.5
nd
–1
.5
–1
.6
–1
0.
1
W
eig
ht
* (
SD
)
–2
.6
–0
.8
–2
.5
+0
.3
nd
–0
.8
–2
.0
–7
.1
Ag
e*
9 
y 9
 m
o
3 
y 2
 m
o
4 
y 9
 m
o
2 
y 4
 m
o
nd
7 
y 7
 m
o
2 
y 7
 m
o
7 
m
o
D
ev
elo
pm
en
t/I
D
m
ild
ly
 re
ta
rd
ed
m
ild
ly
 re
ta
rd
ed
de
lay
ed
 at
 th
e b
eg
in
ni
ng
, 
no
w 
no
rm
al
sli
gh
tly
 d
ela
ye
d
nd
de
lay
ed
 at
 th
e b
eg
in
ni
ng
,
no
w 
no
rm
al
no
rm
al
m
ar
ke
dl
y d
ela
ye
d 
Sp
ee
ch
36
 m
o
fir
st 
wo
rd
s: 
<1
2 
m
o
fir
st 
wo
rd
s: 
30
 m
o
fir
st 
wo
rd
s: 
12
 m
o
nd
fir
st 
wo
rd
s: 
12
 m
o,
 d
ys
lal
ia
 u
nt
il 
6 
y, 
rh
in
ol
ali
a u
nt
il 
no
w 
be
ca
us
e 
of
 ve
lo
ph
ar
yn
ge
al 
in
su
ffi
cie
nc
y
fir
st 
wo
rd
s: 
9 
m
o
nd
Si
tti
ng
 an
d
wa
lk
in
g
wa
lk
in
g:
 3
0 
m
o
sit
tin
g:
 8
 m
o 
wa
lk
in
g:
 1
9 
m
o
sit
tin
g:
 1
4 
m
o 
wa
lk
in
g:
 2
0 
m
o
sit
tin
g:
 1
0 
m
o 
wa
lk
in
g:
 1
5 
m
o
nd
sit
tin
g:
 6
 m
o 
wa
lk
in
g:
 1
5 
m
o
sit
tin
g:
 1
0 
m
o 
wa
lk
in
g:
 1
3 
m
o
nd
H
ai
r a
nd
 sk
in
sp
ar
se
 h
ai
r, 
hi
gh
 
an
te
rio
r h
ai
rli
ne
fu
ll 
ha
ir,
 h
ig
h 
an
te
rio
r h
ai
rli
ne
sp
ar
se
 h
ai
r, 
hi
gh
 an
te
rio
r 
ha
irl
in
e, 
at
ro
ph
ic 
sk
in
 o
f 
th
e h
ea
d
sp
ar
se
 h
ai
r, 
hi
gh
 
an
te
rio
r h
ai
rli
ne
hi
gh
 an
te
rio
r 
ha
irl
in
e
at
ro
ph
ic 
sk
in
 o
f t
he
 h
ea
d,
fa
ce
 an
d 
be
lly
 in
 in
fa
nc
y,
hi
gh
 an
te
rio
r h
ai
rli
ne
sp
ar
se
 h
ai
r, 
hi
gh
 an
te
rio
r 
ha
irl
in
e, 
at
ro
ph
ic 
sk
in
 o
n 
th
e n
os
e, 
se
ve
ra
l t
ela
ng
i-
ec
ta
sia
s
sp
ar
se
 h
ai
r, 
hi
gh
 an
te
rio
r h
ai
rli
ne
, e
ye
-
br
ow
s a
nd
 ey
ela
sh
es
, p
ro
m
in
en
t v
es
se
ls,
 
lea
th
er
y s
ki
n,
 m
or
e d
ee
pl
y p
ig
m
en
te
d 
ba
ck
, l
ac
k 
of
 su
bc
ut
an
eo
us
 fa
t
Cr
an
io
fa
cia
l f
ea
tu
re
s
H
ea
d
br
oa
d 
fo
re
he
ad
fro
nt
al 
bo
ss
in
g
br
oa
d 
fo
re
he
ad
fro
nt
al 
bo
ss
in
g,
 
sh
or
t n
ec
k
br
oa
d 
fo
re
he
ad
lar
ge
 u
pp
er
 h
ea
d,
 h
yp
op
las
tic
 
fa
cia
l b
on
es
, s
ho
rt 
ne
ck
 
fro
nt
al 
bo
ss
in
g
pr
om
in
en
t a
nd
 b
ro
ad
 fo
re
he
ad
,
sh
or
t n
ec
k
 
Ey
e
co
ng
en
ita
l c
at
a-
ra
ct
s, 
rig
ht
 ey
e 
sm
all
er
 th
an
 le
ft,
 
ny
sta
gm
us
, 
bl
ue
 sc
ler
ae
co
ng
en
ita
l c
at
ar
ac
ts,
 
m
icr
op
ht
ha
lm
ia
 b
l 
(le
ft 
m
or
e 
pr
on
ou
nc
ed
)
co
ng
en
ita
l c
at
ar
ac
ts,
 
do
wn
sla
nt
ed
 p
alp
eb
ra
l 
fis
su
re
s
m
icr
op
ht
ha
lm
ia
, 
str
ab
ism
co
ng
en
ita
l c
at
a-
ra
ct
s, 
m
icr
o-
ph
th
alm
ia
 b
l
m
icr
op
ht
ha
lm
ia
, n
ys
ta
gm
us
, 
co
nv
er
ge
nt
 st
ra
bi
sm
, a
m
bl
yo
pi
a
co
ng
en
ita
l c
at
ar
ac
ts,
 
m
icr
op
ht
ha
lm
ia
 b
l, 
pa
pi
lle
de
m
a b
l
co
ng
en
ita
l c
at
ar
ac
ts,
 m
icr
op
ht
ha
lm
ia
, 
de
ep
ly
 se
t e
ye
s 
N
os
e
lo
ng
, t
hi
n
sm
all
, p
oi
nt
ed
sm
all
, n
ar
ro
w 
na
sa
l t
ip
 
an
d 
rig
de
, u
nd
er
de
ve
l-
op
ed
 al
ae
 n
as
i
sm
all
, u
nd
er
de
ve
l-
op
ed
 al
ae
 n
as
i
sm
all
 an
d 
po
in
te
d,
 u
nd
er
-
de
ve
lo
pe
d 
ala
e 
na
si
sh
or
t i
n 
in
fa
nc
y, 
no
w 
th
in
sm
all
, n
ar
ro
w 
sm
all
, n
ar
ro
w
M
ou
th
na
rr
ow
,
pr
ot
ru
di
ng
 
to
ng
ue
na
rr
ow
, t
hi
n 
ve
rm
il-
lio
n 
bo
rd
er
, h
ig
h-
ar
ch
ed
 p
ala
te
na
rr
ow
 w
ith
 th
in
 li
ps
na
rr
ow
nd
na
rr
ow
, h
ig
h 
ar
ch
ed
 p
ala
te
na
rr
ow
, h
ig
h-
ar
ch
ed
 p
ala
te
na
rr
ow
Te
et
h
ne
on
at
al
ne
on
at
al,
 m
ax
ill
a: 
lac
ks
 2
 in
cis
or
s, 
m
an
di
bl
e: 
pa
rtl
y 
do
ub
le-
ro
we
d
ne
on
at
al
ab
no
rm
al,
 
ov
er
cr
ow
de
d,
 
m
alo
cc
lu
sio
n,
op
en
 b
ite
ne
on
at
al
ab
no
rm
al,
 o
ve
rc
ro
wd
ed
 in
cis
or
s, 
m
alo
cc
lu
sio
n,
 o
pe
n 
bi
te
fir
st 
to
ot
h 
>2
0 
m
o,
1 
m
ax
ill
a i
nc
iso
r r
ig
ht
 
lac
ki
ng
, i
nc
lin
ed
 
ar
ra
ng
em
en
t o
f t
he
 te
et
h
–
M
an
di
bl
e
m
icr
o-
re
tro
gn
at
hi
a
m
icr
or
et
ro
gn
at
hi
a
m
icr
or
et
ro
gn
at
hi
a
m
icr
or
et
ro
gn
at
hi
a, 
fla
t m
an
di
bu
lar
 
an
gl
e
re
ce
di
ng
hy
po
pl
as
tic
 m
an
di
bl
e w
ith
 
in
cr
ea
se
d 
an
gl
e d
ue
 to
an
te
rio
r d
isp
lac
em
en
t o
f t
he
 
te
m
po
ro
m
an
di
bu
lar
 jo
in
t
m
icr
og
na
th
ia
m
icr
og
na
th
ia
O
th
er
 an
om
ali
es
bo
dy
 as
ym
m
et
ry
 
wi
th
 a 
sm
all
er
 le
ft 
sid
e, 
re
cu
rr
en
t 
in
fe
ct
io
ns
 o
f t
he
 
up
pe
r a
irw
ay
s
lo
w-
se
t e
ar
s
dy
sp
las
tic
 au
ric
les
, 
hi
p 
dy
sp
las
ia
ap
no
ea
, r
ec
ur
-
re
nt
 p
ne
um
o-
ni
as
dy
sp
las
tic
 au
ric
les
, h
ip
 d
ys
pl
as
ia
, 
ce
rv
ica
l-t
ho
ra
cic
 sc
ol
io
sis
, t
hi
n 
ca
lv
ar
iu
m
 w
ith
 o
ss
al 
de
fe
ct
s, 
na
rr
ow
 ve
rte
br
al 
tu
be
, s
ca
pu
lae
 
ala
ta
e, 
m
yo
to
ni
c r
ea
ct
io
n 
in
 
EM
G
, u
m
bi
lic
al 
he
rn
ia
 o
pr
og
re
ss
iv
e s
no
rin
g 
wi
th
 
ag
gr
av
at
e b
re
at
hi
ng
, 
 re
cu
rr
en
t i
nf
ec
tio
ns
 o
f t
he
 
up
pe
r a
irw
ay
s, 
ap
no
ea
po
ly
m
icr
og
yr
ia
, h
yp
op
las
ia
 o
f c
c, 
cb
 
an
d 
bg
, n
ar
ro
wi
ng
 o
f f
or
am
en
 m
ag
nu
m
 
an
d 
of
 sp
in
al 
ca
na
l a
t c
ra
ni
oc
er
vi
ca
l 
ju
nc
tio
n,
 la
rg
e p
er
im
em
br
an
e V
SD
, 
ov
er
rid
in
g 
of
 ao
rta
, D
CR
V
, h
ep
at
o-
m
eg
aly
, h
ip
 d
ys
pl
as
ia
, c
lu
bf
oo
t r
, 
 pl
an
ov
alg
us
 l,
 th
um
b 
m
alp
os
iti
on
 an
d 
fle
xi
on
 co
nt
ra
ct
ur
e b
l, 
hy
po
sp
ad
ia
, 
 in
gu
in
al 
he
rn
ia
 l,
 b
en
d 
in
 p
en
is 
sh
af
t, 
po
or
 w
eig
ht
 g
ai
n
b g
, B
as
al
 ga
ng
lia
; b
l, b
ila
te
ra
l; C
, C
au
ca
sia
n;
 cb
, c
er
eb
el
lu
m
; c
c, 
co
rp
us
 ca
llo
su
m
; D
CR
V,
 d
ou
bl
e-
ch
am
be
re
d 
rig
ht
 ve
nt
ric
le
; E
M
G
, e
le
ct
ro
m
yo
gr
ap
hy
; F
, f
em
al
e; 
ID
, i
nt
el
le
ct
ua
l d
isa
bi
lit
y;
 l, 
le
ft;
 M
, m
al
e; 
m
o,
 m
on
th
s; 
nd
, n
ot
 
do
cu
m
en
te
d;
 o
, o
pe
ra
te
d 
at
 th
e a
ge
 o
f 3
 m
on
th
s; 
r, 
rig
ht
; S
D
, s
ta
nd
ar
d 
de
vi
at
io
n;
 V
SD
, v
en
tr
ic
ul
ar
 se
pt
al
 d
ef
ec
t; 
y, 
ye
ar
(s)
; +
, p
re
se
nt
; –
, a
bs
en
t; 
*, 
at
 la
st 
fo
llo
w-
up
.
a  D
ie
d 
at
 th
e a
ge
 o
f 1
3 
m
on
th
s f
ro
m
 p
ne
um
on
ia
; b
 d
ie
d 
at
 th
e a
ge
 o
f 7
 m
on
th
s.
 Hallermann-Streiff Syndrome Mol Syndromol 2011;2:27–34 31
 Next, we sequenced the coding region and adjacent 
intronic sequences of the 3 genes  LMNA, ZMPSTE24 , and 
 ICMT in the 8 patients with HSS. Patient 1 was homozy-
gous for the intronic sequence variation c.1158–44C 1 T in 
the  LMNA gene that was found in her mother in the het-
erozygous state, while the father was not available (data 
not shown and online suppl. table 2). In silico analysis us-
ing 3 splice site prediction programs revealed that c.1158–
44C 1 T potentially creates a new splice donor site (online 
suppl. table 3) and could result in altered splicing. How-
ever, our RNA analysis did not uncover any aberrant 
 LMNA transcript in patient 1 compared with 2 healthy 
individuals (data not shown). In patient 2, we identified 
the heterozygous missense mutation c.1930C 1 T 
(p.R644C) in exon 11 of  LMNA (online suppl. table 2) that 
has been described in patients with a wide spectrum of 
phenotypes [Rankin et al., 2008]. This mutation was also 
found in the asymptomatic mother of patient 2 (data not 
shown). In addition, 5 known single-nucleotide polymor-
phisms (SNPs) were detected in the  LMNA gene (online 
suppl. table  2). Sequencing of the  ZMPSTE24 gene re-
vealed 2 SNPs (online suppl. table 2). As the only sequence 
alteration in the  ICMT gene, we found a heterozygous du-
plication of 24 bp (c.–41_–64dup24) in the 5  untrans-
lated region in patient 1 (online suppl. table 2). 
A B
 Fig. 1. Facial appearance of patients 1, 2, 3, 6 and 7 with HSS. 
Numbers refer to patient numbers.  A Frontal view and  B lateral 
view of the patients. All patients show the typical facial appear-
ance with malformations of the cranium and facial bones, frontal 
bossing, pointed nose, narrow mouth, and micrognathia. Mi-
crophthalmia is present in patients 1, 2, 6 and 7. Except for patient 
2, all individuals have sparse hair. (Photographs submitted with 
written consent from the patient’s legal guardian for publication 
in print and online.)  
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 Fig. 2. Representative nuclear morphology of fibroblast cells de-
rived from patients 1 and 5 with HSS and a control. Cells were 
labeled with a monoclonal mouse anti-human lamin A/C anti-
body and a secondary Alexa Fluor 546 anti-mouse IgG (left pan-
el). The same cells are shown by phase-contrast microscopy in the 
right panel. Scale bar: 10   m. 
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 Discussion 
 In this study, we aimed to gain insight into the patho-
physiological and/or genetic basis of HSS, a rare develop-
mental disorder for which the causative gene has not been 
identified to date. 
 We present 8 patients with clinical features of HSS, in-
cluding individuals 1, 3, 5, and 7 with the characteristic 
manifestations of HSS ( fig. 1 ,  table 1 ) and male patient 8 
with the typical facial appearance (facial photographs of 
this patient could not be shown because of lack of con-
sent) and very severe abnormalities affecting various or-
gan systems ( table 1 ). In detail, he showed markedly de-
layed development, several brain malformations, con-
genital heart defects, skeletal abnormalities, hypospadia, 
and left inguinal hernia and died at the age of 7 months. 
Such a combination of severe organ manifestations is un-
usual in HSS; however, several patients with the classical 
facial appearance and additional atypical clinical features 
have been reported in the literature. For example, bone 
fractures have been described in severe (lethal and non-
lethal) forms of HSS [Dennis et al., 1995; Ertekin et al., 
2004]; cryptorchidism, clitorial enlargement, and hypo-
spadia have been documented in some patients [Cohen, 
1991]. Hemihypertrophy has also been associated with 
HSS [Dogan et al., 2010], and various congenital heart 
defects, comprising valvular pulmonary stenosis, patent 
ductus arteriosus, ventricular and atrial septal defects are 
not uncommon in HSS [Imaizumi et al., 1994 and refer-
ences therein; David et al., 1999]. Agenesis of the corpus 
callosum has been seen in a 4-year-old boy with HSS and 
other complications, such as bilateral inguinal hernia 
with cryptorchidism and a small penis [Sigirci et al., 
2005]. The 2-month-old girl described by Hou [2003] also 
had rare anomalies in addition to the characteristic fea-
tures of HSS. She presented with choanal atresia, small 
cerebellum, hypothyroidism, and generalized organic ac-
iduria [Hou, 2003]. Although most of the patients with 
HSS have normal intelligence, intellectual disability 
ranging from mild to severe has been documented [Co-
hen, 1991; David et al., 1999]. Taken together, most of the 
patients with HSS have the classical manifestations; how-
ever, the natural variations of the clinical spectrum might 
include mild and severe HSS, or ‘variant forms’ as specu-
lated earlier [Verloes, 1997]. As long as the genetic etiol-
ogy of this syndrome remains unknown, it is still under 
discussion whether the different manifestations in pa-
tients with HSS represent distinct genetic entities as they 
could overlap with e.g. ODDD [Spaepen et al., 1991], os-
teocraniostenosis [Verloes, 1997], Wiedemann-Rauten-
strauch syndrome, and MAD [Cohen, 1991]. In addition, 
genetic heterogeneity can not be excluded in patients with 
HSS and different severity. 
 The report on a 36-fold increased chromosome break-
age rate in a patient with the principal manifestations of 
HSS [Hou, 2003] prompted us to investigate the chromo-
some breakage rate in our patients. Normal chromosome 
breakage rate in 4 patients with HSS indicates that defec-
tive DNA recombination and/or recombination repair is 
not likely to be associated with this disorder. 
 Progeroid appearance in patients with HSS as well as 
dental anomalies, mandibular hypoplasia, skin atrophy, 
hypotrichosis, and short stature are also common fea-
tures in patients with HGPS and MAD. Most of the typi-
cal patients with HGPS have a recurrent de novo  LMNA 
mutation, resulting in a lamin A protein which lacks 50 
amino acids near the C-terminus, including the second 
cleavage site for ZMPSTE24. The mutant form of lamin 
A can be processed at the CAAX motif, including meth-
ylation by ICMT, but fails to be cleaved by ZMPSTE24 
and is permanently farnesylated and carboxylmethylated 
[Young et al., 2006]. As mutations in  ZMPSTE24 itself 
also result in a progeroid disorder [Worman and Bonne, 
2007], the hypothesis has been put forward that the 
amount of accumulated farnesyl-prelamin A determines 
the severity in disease [Young et al., 2006; Barrowman 
and Michaelis, 2009]. Farnesyl-prelamin A and other 
lamin A mutant proteins are targeted to the nuclear en-
velope, where they disrupt the integrity of the nuclear 
lamina and interfere with the nuclear architecture [Wor-
man and Bonne, 2007]. We studied the nuclear morphol-
ogy in skin fibroblasts of 2 patients with HSS and could 
not find any alteration. However, nuclear abnormalities 
have been identified only in a subset of fibroblasts from 
patients with  LMNA mutations [Muchir et al., 2004]. We 
therefore analyzed the genes  LMNA, ZMPSTE24 and 
 ICMT for mutations in the 8 patients with HSS. In patient 
2, we identified the heterozygous  LMNA mutation 
c.1930C 1 T (p.R644C) that has been considered as a 
pathogenic missense mutation [Rankin et al., 2008]. Ar-
ginine at position 644 is part of the cleavage recognition 
sequence for ZMPSTE24 which removes the 15 C-termi-
nal amino acids of prelamin A [Kilic et al., 1997]. If sub-
stitution of arginine by cysteine results in abnormal pro-
cessing of prelamin A, accumulation of unprocessed 
prelamin A would be expected in cells of individuals with 
this  LMNA alteration, resulting in a progeria-like pheno-
type. Indeed, a patient with p.R644C and atypical proge-
ria has been described [Csoka et al., 2004], but although 
the nuclear shape of the patient’s cells showed some ab-
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normalities, accumulation of prelamin A has not been 
detected [Toth et al., 2005]. The p.R644C mutation has 
been previously linked to extreme phenotypic diversity 
including lipodystrophy, insulin resistance, motor neu-
ropathy, dilated cardiomyopathy, left ventricular hyper-
trophy, limb girdle muscle weakness, hepatic steatosis, 
and atypical progeria [Genschel et al., 2001; Csoka et al., 
2004; Mercuri et al., 2005; Muntoni et al., 2006; Rankin 
et al., 2008; Møller et al., 2009; Perrot et al., 2009]. All pa-
tients with the p.R644C mutation had features of lami-
nopathies, but some showed additional complications 
such as renal disease with focal segmental glomeruloscle-
rosis, growth retardation, micrognathia, sensorineural 
hearing loss, and congenital contractures with club foot 
[Rankin et al., 2008]. The phenotype of patient 2 is not 
typical of laminopathies as she presented with ocular 
anomalies, such as bilateral congenital cataracts, mi-
crophthalmia of the left eye in addition to short stature, 
a small and thin nose, a thin vermillion border, and mi-
croretrognathia that are all manifestations seen in pa-
tients with HSS. Although compelling evidence exists 
that the p.R644C mutation in  LMNA is pathogenic, non-
penetrance of this sequence change in many first-degree 
relatives [Rankin et al., 2008; this report] and the pres-
ence of this alteration in 0.8% of the Danish population 
[Møller et al., 2009] suggested that a second mutation 
could be considered in affected individuals with p.R644C 
[Muntoni et al., 2006]. Accordingly, the p.R644C muta-
tion might have contributed to the phenotype of patient 
2; however, the failure to identify any pathogenic  LMNA 
mutation in the other 7 patients with HSS suggests that 
 LMNA is not the major gene for this syndrome. In line 
with this conclusion, the homozygous c.1158–44C 1 T 
mutation in  LMNA in patient 1 did not turn out to be 
pathogenic. Although in silico analysis predicted the cre-
ation of a new splice donor site in intron 6,  LMNA tran-
script analysis in this patient did not reveal any evidence 
for aberrant splicing. 
 We identified 2 SNPs and 1 small rearrangement in the 
5  -untranslated region of the genes  ZMPSTE24 and 
 ICMT , respectively, which we believe are rather benign 
polymorphisms than pathogenic mutations (online 
suppl. table 2). Nonetheless, we can not rule out molecu-
lar lesions in the 3 genes that escaped detection by our 
mutation screening, such as large exon-spanning dele-
tions, inversions and duplications, changes in the 5  and 
3  untranslated regions, and promoter defects. Taken to-
gether, our data provide evidence that HSS does not be-
long to the laminopathies, although we cannot yet ex-
clude that the underlying genetic basis of HSS may be 
linked to the nuclear envelope and associated proteins. 
 Exome sequencing is the method of choice for identi-
fying the pathogenic mutation in patients with HSS in the 
future, as this approach has been successfully used for 
other rare monogenic disorders [Ku et al., 2011]. HSS 
could be caused by a germline or somatic mutation. 
Therefore, DNA isolated from affected and unaffected 
tissues might be useful to detect the causative variant in 
the small series of patients. Indeed, exome sequencing 
successfully identified a mosaic mutation in the  AKT1 
gene in patients with Proteus syndrome [Lindhurst et al., 
2011]. 
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